Abstract
Background
Up to 50% of all women encounter benign breast problems. In contrast to breast cancer, high-level evidence is not available to guide treatment. Management is therefore largely based on individual physician experience/training. The American board of internal medicine (ABIM) initiated its Choosing Wisely® campaign to promote conversations between patients and physicians about challenging the use of tests or procedures which may not be necessary. The American society of breast surgeons (ASBrS) Patient safety and quality committee (PSQC) chose to participate in this campaign in regard to the management of benign breast disease.
Methods
The PSQC solicited initial candidate measures. PSQC surgeons represent a wide variety of practices. The resulting measures were ranked by modified Delphi appropriateness methodology in two rounds. The final list was approved by ASBrS and endorsed by the ABIM.
Results
The final five measures are as follows. (1) Don’t routinely excise areas of pseuodoangiomatous stromal hyperplasia (PASH) of the breast in patients who are not having symptoms from it. (2) Don’t routinely surgically excise biopsy-proven fibroadenomas that are < 2 cm. (3) Don’t routinely operate for a breast abscess without an initial attempt to percutaneously aspirate. (4) Don’t perform screening mammography in asymptomatic patients with normal exams who have less than a 5-years life expectancy. (5) Don’t routinely drain nonpainful, fluid-filled cysts.
Conclusions
The ASBrS Choosing Wisely® measures that address benign breast disease management are easily accessible to patients via the internet. Consensus was reached by PSQC regarding these recommendations. These measures provide guidance for shared decision-making.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Levinson W, Kallewaard M, Bhatia RS, et al. “Choosing Wisely”: a growing international campaign. BMJ Qual Saf. 2015;24:167–74.
Landercasper J, Bailey L, Berry TS, et al. Measures of appropriateness and value for breast surgeons and their patients: the American Society of Breast Surgeons Choosing Wisely ((R)) Initiative. Ann Surg Oncol. 2016;23:3112–8.
American College of O, Gynecologists’ Committee on Practice B-G. Practice Bulletin No. 164: diagnosis and management of benign breast disorders. Obstet Gynecol. 2016;127:e141–56.
Morrow M. The evaluation of common breast problems. Am Fam Physician. 2000;61:2371–78, 2385.
Fitch K. The Rand/UCLA appropriateness method user’s manual. Santa Monica: Rand, 2001.
Drinka EK, Bargaje A, Ersahin CH, et al. Pseudoangiomatous stromal hyperplasia (PASH) of the breast: a clinicopathological study of 79 cases. Int J Surg Pathol. 2012;20:54–8.
Hargaden GC, Yeh ED, Georgian-Smith D, et al. Analysis of the mammographic and sonographic features of pseudoangiomatous stromal hyperplasia. AJR Am J Roentgenol. 2008;191:359–63.
Amin AL, Purdy AC, Mattingly JD, Kong AL, Termuhlen PM. Benign breast disease. Surg Clin North Am. 2013;93:299–308.
Lee S, Mercado CL, Cangiarella JF, Chhor CM. Frequency and outcomes of biopsy-proven fibroadenomas recommended for surgical excision. Clin Imaging. 2017;50:31–6.
Hubbard JL, Cagle K, Davis JW, Kaups KL, Kodama M. Criteria for excision of suspected fibroadenomas of the breast. Am J Surg. 2015;209:297–301.
Kuijper A, Mommers EC, van der Wall E, van Diest PJ. Histopathology of fibroadenoma of the breast. Am J Clin Pathol. 2001;115:736–42.
Trop I, Dugas A, David J, et al. Breast abscesses: evidence-based algorithms for diagnosis, management, and follow-up. Radiographics. 2011;31:1683–99.
Lam E, Chan T, Wiseman SM. Breast abscess: evidence based management recommendations. Expert Rev Anti Infect Ther. 2014;12:753–62.
Eryilmaz R, Sahin M, Hakan Tekelioglu M, Daldal E. Management of lactational breast abscesses. Breast. 2005;14:375–9.
Naeem M, Rahimnajjad MK, Rahimnajjad NA, Ahmed QJ, Fazel PA, Owais M. Comparison of incision and drainage against needle aspiration for the treatment of breast abscess. Am Surg. 2012;78:1224–7.
Myers ER, Moorman P, Gierisch JM, et al. Benefits and harms of breast cancer screening: a systematic review. JAMA. 2015;314:1615–34.
Lee CS, Moy L, Joe BN, Sickles EA, Niell BL. Screening for breast cancer in women age 75 years and older. AJR Am J Roentgenol. 2018;210:256–63.
McPherson CP, Swenson KK, Lee MW. The effects of mammographic detection and comorbidity on the survival of older women with breast cancer. J Am Geriatr Soc. 2002;50:1061–8.
Schonberg MA. Decision-making regarding mammography screening for older women. J Am Geriatr Soc. 2016;64: 2413–8.
Rinaldi P, Ierardi C, Costantini M, et al. Cystic breast lesions: sonographic findings and clinical management. J Ultrasound Med. 2010;29:1617-26.
Berg WA, Sechtin AG, Marques H, Zhang Z. Cystic breast masses and the ACRIN 6666 experience. Radiol Clin North Am. 2010;48:931–87.
Brenner RJ, Bein ME, Sarti DA, Vinstein AL. Spontaneous regression of interval benign cysts of the breast. Radiology. 1994;193:365–8.
Porter ME, Teisberg EO. Redefining health care: creating value-based competition on results. Boston, MA: Harvard Business School Press, 2006.
Fayanju OM, Mayo TL, Spinks TE, et al. Value-based breast cancer care: a multidisciplinary approach for defining patient-centered outcomes. Ann Surg Oncol. 2016;23:2385–90.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rao, R., Ludwig, K., Bailey, L. et al. Select Choices in Benign Breast Disease: An Initiative of the American Society of Breast Surgeons for the American Board of Internal Medicine Choosing Wisely® Campaign. Ann Surg Oncol 25, 2795–2800 (2018). https://doi.org/10.1245/s10434-018-6584-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-018-6584-5